Phase 2 Readout
ACAD: Phase 2 Readout: remlifanserin
December 31, 2026 · remlifanserin. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- ACADIA PHARMACEUTICALS INC (ACAD)
- Drug
- remlifanserin
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: remlifanserin
- Drug
- remlifanserin
- Indication
- Alzheimer's disease psychosis